GLP-1 for Women in Malaysia: Hormones, PCOS & Weight Loss

Polycystic ovary syndrome (PCOS) affects an estimated 5 to 15 percent of women of reproductive age in Malaysia, and weight gain is one of its most frustrating and persistent symptoms. If you have PCOS and have struggled to lose weight despite dieting and exercise, you are not alone. The difficulty is not a lack of willpower. This article explains why PCOS makes weight loss harder and how GLP-1 medication may help.

Why Weight Loss Is Harder for Women with PCOS

PCOS is fundamentally a hormonal and metabolic disorder, not just a reproductive one. Up to 70 percent of women with PCOS have some degree of insulin resistance, meaning their cells do not respond normally to insulin, so the body produces more of it to compensate. This excess insulin promotes fat storage (particularly around the abdomen), makes it harder to burn stored fat for energy, and drives persistent hunger and cravings for high-carbohydrate foods.

The hormonal imbalance in PCOS compounds the problem further. Elevated androgens (male hormones like testosterone), which are characteristic of PCOS, are associated with increased visceral fat, the metabolically active fat that wraps around internal organs and is linked to cardiovascular disease and Type 2 diabetes. This creates a vicious cycle: excess weight worsens insulin resistance, which worsens hormonal imbalance, which makes it even harder to lose weight.

Studies show that women with PCOS typically have a lower basal metabolic rate than women of the same age and weight without the condition, meaning they burn fewer calories at rest. This metabolic disadvantage means that standard calorie-reduction diets often produce disappointing results. Many women with PCOS report that they eat less than their peers yet still gain weight, and the science supports their experience.

How GLP-1 Medication Helps Women with PCOS

GLP-1 receptor agonists address several of the core metabolic dysfunctions that make weight loss so difficult for women with PCOS. First and most importantly, they significantly improve insulin sensitivity. By helping cells respond better to insulin, GLP-1 medication reduces the excess insulin levels that drive fat storage and carbohydrate cravings. This breaks the metabolic cycle that keeps many women with PCOS trapped at a higher weight.

Second, GLP-1 medications act on appetite centres in the brain to reduce hunger and increase satiety. For women with PCOS who experience intense, hormonally driven cravings, particularly for sugary and starchy foods. This appetite suppression can be transformative. Patients frequently describe it as finally feeling in control of their eating for the first time, rather than constantly fighting against their body's signals.

Clinical research specifically studying GLP-1 agonists in women with PCOS has shown promising results. Studies have demonstrated that liraglutide and semaglutide produce meaningful weight loss in PCOS patients, with some trials showing average reductions of 6 to 12 percent of body weight over 6 months. Importantly, this weight loss was accompanied by improvements in insulin resistance markers, fasting glucose levels, and hormonal profiles, suggesting benefits that go well beyond the number on the scale.

GLP-1 and Hormonal Balance

One of the most significant benefits of GLP-1-assisted weight loss for women with PCOS is its downstream effect on hormonal balance. As body fat decreases, particularly visceral abdominal fat. Androgen levels tend to decline naturally. Many women on GLP-1 treatment report improvements in PCOS symptoms that are directly linked to excess androgens: reduction in unwanted facial and body hair growth, improvement in hormonal acne, decreased oiliness of the skin, and return of more regular menstrual cycles.

For women with PCOS who are trying to conceive, the hormonal improvements associated with weight loss can be particularly meaningful. Excess weight and insulin resistance are among the leading causes of anovulation (failure to ovulate) in PCOS. Research has shown that even a modest weight loss of 5 to 10 percent of body weight can restore ovulation in some women with PCOS. While GLP-1 medications are not fertility treatments and must be discontinued before pregnancy, the weight loss and metabolic improvements achieved during treatment can create more favourable conditions for conception afterwards. Always discuss family planning with your doctor before starting any medication.

Who Qualifies for GLP-1 Treatment with PCOS?

In Malaysia, GLP-1 medication for weight loss is typically prescribed for patients with a BMI of 27.5 or above (using Asian-specific thresholds) or a BMI of 25 or above with at least one weight-related comorbidity, and PCOS with insulin resistance qualifies as a comorbidity. Your doctor will assess your full medical history, current medications, and health goals before determining whether GLP-1 treatment is appropriate for you.

Many women with PCOS are already taking metformin, which is commonly prescribed to address insulin resistance. GLP-1 medication can generally be used alongside metformin, and some research suggests the combination may be more effective than either treatment alone for weight loss and metabolic improvement in PCOS patients. Your doctor will review your current medication regimen and adjust doses as needed. Other PCOS medications such as oral contraceptives or anti-androgen treatments can typically continue alongside GLP-1 therapy, but this should always be discussed with your prescribing physician.

What to Expect: Results Timeline for Women with PCOS

Weight loss with GLP-1 medication in women with PCOS tends to follow a predictable pattern, though individual results vary. Here is a general timeline based on clinical experience and published research:

It is important to set realistic expectations. Women with PCOS may lose weight slightly more slowly than women without the condition, particularly in the first few months. This is normal and reflects the underlying metabolic challenges of PCOS. It does not mean the treatment is not working. Consistency with medication, nutrition, and doctor follow-ups is key.

Getting Started with Seimbang

If you have PCOS and are considering GLP-1 treatment, the first step is a comprehensive medical assessment. At Seimbang, our licensed Malaysian doctors understand the unique challenges that women with PCOS face when trying to lose weight. We will review your medical history, current medications including metformin and any hormonal treatments, blood work, and health goals before recommending a personalised treatment plan.

Our 5-minute online eligibility assessment is free and confidential. You will answer questions about your health history, current weight and height, medications, and goals. A Seimbang doctor will review your assessment and let you know whether GLP-1 treatment is appropriate for your situation. If it is, we will discuss the best medication option, dosing schedule, and monitoring plan tailored to your PCOS. If it is not the right fit, we will be upfront about that and suggest alternatives.